Michael Kyriakides
Direktor/Vorstandsmitglied bei Purespring Therapeutics Ltd.
Aktive Positionen von Michael Kyriakides
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 01.08.2018 | - |
Purespring Therapeutics Ltd.
 Purespring Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Purespring Therapeutics Ltd. provides biotechnological research and experimental development services. The company was founded on April 1, 2020 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | 01.04.2022 | - |
Karriereverlauf von Michael Kyriakides
Ausbildung von Michael Kyriakides
| Imperial College London | Doctorate Degree |
Statistik
International
| Vereinigtes Königreich | 4 |
Operativ
| Doctorate Degree | 2 |
| Undergraduate Degree | 2 |
| Private Equity Investor | 1 |
Sektoral
| Finance | 2 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Finance |
Purespring Therapeutics Ltd.
Purespring Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Purespring Therapeutics Ltd. provides biotechnological research and experimental development services. The company was founded on April 1, 2020 and is headquartered in London, the United Kingdom. | Commercial Services |
- Börse
- Insiders
- Michael Kyriakides
- Erfahrung
